Background: The aims of the study were to investigate measurement reactivity in sedentary behavior (SB), physical activity (PA), and accelerometer wear time in two measurement periods, to examine the reproducibility of these outcomes and to quantify measurement reactivity as a confounder for the reproducibility of SB and PA data.
Background In order to determine the level of sedentary behavior (SB) and physical activity (PA), to understand their relationship with health, and to evaluate the efficacy of behavioral interventions, an accurate measure of SB and PA is required. 1 This is challenging because both behaviors are characterized by considerable inter-and intraindividual variability. 2 Day-to-day variability around a mean level is a natural part of SB and PA and is described as the habitual level of SB and PA of an individual. 3, 4 This behavioral variability needs to be carefully studied because it has major implications for measurement and conclusions, drawn from data analysis. 4 Accelerometry is frequently used to assess SB and PA. The reproducibility of accelerometer-based measures might be subject to human-related sources of bias. 5 Participants can influence accurate data measurement by changing their behavior when they know that they are wearing an accelerometer to assess habitual levels of SB and PA. 6 The motivation to be physically more active than usual due to wearing such a device or social desirability may be reasons for the presence of accelerometer measurement reactivity (AMR). 7 Particularly in behavioral intervention studies, potential effects of (repeated) assessments themselves may cloud effects of the intervention by improving self-monitoring and awareness of the behavior being measured, possibly resulting in behavior change in the intervention group as well as in the control group. 8, 9 So far, evidence on AMR among adults is inconsistent 8, [10] [11] [12] [13] [14] [15] and mostly limited to young adults or small sample sizes. [11] [12] [13] [14] Further, there appears to be only the study of Baumann and colleagues examining the influence of AMR on SB and the entire intensity spectrum of PA.
The analysis was carried out using the same sample as in the present study but referred to baseline data only. 15 To our best knowledge, none of the studies investigating AMR has examined whether and to what extent AMR occurs in more than one measurement period, particularly in the context of a behavioral intervention. The effect of AMR on repeated assessments of SB and PA could result in an over-or underestimation of baseline values and therefore, in difficulties in detecting changes in SB and PA outcome variables in the long term.
The vast majority of studies applied a 7-day accelerometry protocol to determine habitual levels of SB and PA. 16 However, this approach raises the question whether this length of monitoring protocol is sufficient to reflect the mean level on the entire intensity spectrum from SB to moderate-to-vigorous PA (MVPA). Reliable data depend on the variability within a person's daily activity pattern, 3 especially for more than one measurement period. 17 Moreover, the potential impact of AMR on the reproducibility of SB and PA data was not investigated so far.
Therefore, the present study has two aims. First, to examine AMR over two measurement periods indicated by systematic changes in SB, light PA (LPA), MVPA, and accelerometer wear time. Second, to investigate the reproducibility of these outcomes and to quantify whether AMR should be considered as a relevant confounder to estimate the reproducibility of SB and PA data.
Methods
Study participants: From a sample of 1165 individuals aged between 40 and 70 years who had been recruited in general medical practices, job agencies, or via a health insurance company between June 2012 and December 2013, 95% gave written consent to be contacted again. Of those, a total of 401 persons were offered participation in a randomized-controlled study that aimed to assess the feasibility of a brief tailored letter intervention to increase PA and to reduce SB in leisure time. The design and participant flow were described in detail elsewhere. 18 SB, LPA, and MVPA were measured with accelerometry at baseline (n = 175) and after 12 months (n = 165, 94%). Two participants at each measurement period were excluded due to missing accelerometer data (excluded, n = 4). In addition, we analyzed data only among those who have worn the accelerometer ≥ 10 hours per day (h/day) on ≥ 5 days including at least one weekend day (excluded, n = 25). The final sample size comprised 136 participants.
Procedure: At baseline and after 12 months, all participants underwent the following procedure: (1) cardiovascular health program including blood sample taking and standardized measurement of blood pressure, waist circumference, body weight, and height at the cardiovascular examination center of the University Medicine Greifswald; (2) self-administered assessments of socio-demographics, SB, and PA; (3) wearing an accelerometer for seven consecutive days; and (4) protocolling daily working hours over the monitoring period.
Study participants were instructed to wear the accelerometer on their right hip with an elastic band, to start the day after the cardiovascular health program in the morning after getting dressed, and to take it off during night's sleep and water activities. All participants were informed that PA would be recorded for seven days.
After baseline assessments, participants were randomized into an assessment-only group (n = 85) or an intervention group (n = 90). Additionally, for all participants, selfadministered assessments of SB and PA were conducted at month 1, 3, 4, and 6 after baseline. Only individuals of the intervention group received up to three letters tailored to their self-reported SB and PA at month 1, 3, and 4. The study was conducted between February 2015 and August 2016 and was approved by the clinical ethical committee of the University Medicine Greifswald (protocol number BB 002/15a).
Measures: Accelerometer-based data were assessed using a tri-axial ActiGraph Model GT3X+ accelerometer (Pensacola, FL). The accelerometers were initialized at a sampling rate of 100 Hertz and raw data were integrated into 10-second epochs. Data from the vertical axis were used. For statistical analysis, data from the accelerometers were downloaded and processed using ActiLife software (Version 6.13.3; ActiGraph).
Time spent in SB, LPA, MVPA, and wearing the accelerometer was determined by minutes per day (min/day). Non-wear time was calculated by the Troiano algorithm, defined as at least 60 consecutive minutes of zero activity intensity counts, with allowance for ≤ 2 minutes of counts (counts/min) between 0 and 100. To identify the time spent in different intensities of PA, we used cut points according to different intensity threshold criteria. 19 Values < 100 counts/min were determined as SB, values between 100 and 2019 counts/min as LPA, and values ≥ 2020 counts/min as MVPA. Different intensity activities (LPA and MVPA) or SB were accumulated in bouts of ≥10-minutes, respectively. Sex, age, and years of school education (< 10 years/ 10 to 11 years/ ≥ 12 years) were obtained by a self-administrative questionnaire. In addition, study group (assessment-only group/ intervention group), time (baseline/ after 12 months), recruitment site (general practice/ job center/ health insurance), first day of measurement (weekday/ weekend day), 20 season of data collection (winter/ spring/ summer), 21 and the average number of working hours 4 on each day the accelerometer was worn were included as covariates.
Statistical analyses:
We decided to include data from both study groups as all participants received almost the same assessment procedure, the feasibility study was not powered to detect differences between assessment-only group and intervention group, and previously published data revealed that there were no differences in self-reported PA and SB between groups after 12 months. 18 SB, LPA, and accelerometer wear time were approximately normally distributed, thus untransformed values were used for analyses. To account for their right-skewed distributions, MVPA data were square root transformed. For all analyses, p-values below 0.05 were considered statistically significant.
Latent growth models were used to investigate AMR for both measurement periods. 22 In line with Baumann et al., 15 Rescaled Likelihood Ratio Tests were used to test whether higher order functions of time scores and free growth factor variances were required. 23 Working hours as a time-varying covariate that was specified to predict outcomes at the corresponding day of measurement has been taken into account for all models. Additionally, accelerometer wear time as a time-varying covariate was used in modelling SB and activity outcome variables (LPA and MVPA). Non-zero time trends in the outcomes over the days of measurement would imply reactivity. In the models, the slope factor was freely estimated if appropriate and treated as a reactivity indicator reflecting the individual average change in outcome over time. Therefore, the factor scores of outcomes were saved and included as a reactivity indicator in further analysis. Statistical analyses were performed using Mplus version 7.316. 23 For each outcome, the average of the 7 days of measurement was calculated. Two-level (individual and time) mixed-effects linear regression analyses were performed to assess changes in accelerometer-based outcomes from baseline to 12 months apart, including a random intercept for subjects. All regression models were adjusted for sex, age, education, study group, time, recruitment site, first day of measurement, and season of data collection. In addition, we added the individual average value of accelerometer wear time, the reactivity indicator of the respective SB and PA outcome, and a combination of these factors as potential covariates step-by-step.
We used intraclass correlation (ICC) coefficients to decide which model for each outcome was most appropriate. The ICC is a measure of reproducibility of replicate measures from the same subject. 24 The ICC coefficient is classified as follows: less than 0.4 indicates poor, between 0.4 and 0.75 fair to good, and 0.75 or more excellent reproducibility. 24 To illustrate the agreement between both measurement periods and to estimate the limits of agreement interval (95% Confidence Interval, CI), Bland Altman plots were applied.
Statistical analyses were performed using Stata/ SE version 14.2. 25 
Results
Sample characteristics: In our sample, the mean age was 54.6 years and 65.4% were women. The majority of the participants attended school 10 to 11 years (70.4%). Table 1 provide data on time spent in SB, LPA, and MVPA and wearing the accelerometer from baseline to 12 months.
Accelerometer measurement reactivity: As shown in Figure 1 , at baseline and after 12 months, participants increased time spent in SB by 2.4 min/day (p = 0.033) and by 3.8 min/day (p = 0.001) and reduced time spent in LPA by 2.0 min/day (p= 0.033) and by 3.2 min/day (p = 0.001), respectively. Neither at baseline (β = -0.0; p = 0.701) nor after 12 months (β = -0.0; p = 0.165) participants significantly changed time they spent in MVPA.
Participants significantly reduced the accelerometer wear time by 5.2 min/day (p = 0.030) at baseline. After 12 months, participants did not significantly change accelerometer wear time (β = -0.2; p = 0.935). The reactivity indicators of SB (p = 0.011), and LPA (p = 0.008) significantly differed from baseline to 12 months apart. Results of baseline and after 12 months parameter estimates for latent growth models of SB, LPA, MVPA, and accelerometer wear time are shown in additional file 1 (Tables S1/ S2).
Reproducibility of accelerometer-based outcomes:
The ICC (95% CI) ranged from fair to good reproducibility of the outcomes; coefficient values were between 0.42 (0.32, 0.53) for accelerometer wear time and 0.74 (0.68, 0.79) for SB (additional file 2; Table S3 ). The regression model additionally adjusted for the average value of accelerometer wear time was most appropriate for SB (ICC = 0.74), for LPA (ICC = 0.69), and for MVPA (ICC = 0.70).
For accelerometer wear time, the basic model was used (ICC = 0.42).
The Bland Altman plots visualize the agreement between the two measurement periods, as a function of the mean of these two measurement periods (additional file 3; Figure S1 ).
The plots showed that baseline values in all outcome variables were higher than after 12 months. The mean difference (baseline -after 12 months) of both measurements of SB was 8.8 min/day (SD = 87.9 min/day), LPA was 3.5 min/day (SD = 46.9 min/day), MVPA Using the most appropriate regression model for each outcome, neither the time spent in SB, LPA, MVPA, nor accelerometer wear time significantly declined or increased over time (Table 2 ). In all SB and PA regression models, the average value of accelerometer wear time was a significant confounder.
Discussion
The present study has two main findings. First, there was a significant linear trend in SB and LPA time series as an indicator of AMR for baseline and 12 months apart, whereas MVPA does not seem to be affected by AMR. Further, the systematic changes within accelerometer wear time differed between the two measurement periods. Second, our results showed that the time spent in SB, LPA, and MVPA and wearing the accelerometer are fairly stable between the two measurement periods. AMR operationalized by a reactivity indicator could not be identified as a relevant confounder for the estimation of the reproducibility of SB and PA data.
In line with previous literature, the results of the present study indicate that persons change SB and PA in the presence of an accelerometer. 8, 11, [13] [14] [15] This study adds to the literature by showing that AMR differentially influences SB and PA in two measurement periods depending on the intensity level of PA. As shown by Baumann and colleagues, individuals appeared to replace SB with LPA. 15 LPA includes standing and walking at a light pace, and therefore SB and LPA are highly correlated. 26, 27 In addition, our study shows that the trend of both time series seems to be the same over the two measurement periods. Therefore, it can be assumed that AMR has a similar impact on SB and LPA over time. The best advice for reducing bias due to AMR is to consider this in the planning of the study. 28 In case of interventions, measurement periods in terms of duration and frequency as well as number of methods used to assess SB and PA should be balanced to identify potential intervention effects.
Although the effect sizes of the changes in SB (baseline: d = 0.30; after 12 months: d = 0.50) and LPA (baseline: d = 0.29; after 12 months: d = 0.54) over one measurement period were small to medium, the validity of habitual levels of accelerometer-assessed SB and LPA could be biased due to the background noise of human-related sources of measurement errors. AMR could interact with interventions by masking their potential effects, particularly in behavioral intervention studies that typically expect small-tomedium effect sizes. In addition, there is no consensus in the literature about how many days are relevant to achieve a reliable measurement of habitual levels of SB and PA 29 and over what period of time reactivity seems to last. This leads to different recommendations of monitoring regimes including different length of familiarization periods (two days to one week). 7 Therefore, to what extent AMR may result in an over-or underestimation of SB or LPA remains to be investigated.
Furthermore, our results showed that MVPA seemed to be less altered by AMR than SB and LPA. This could be because of MVPA typically requires more planning and is likely to be more structured than lighter physical activities. However, it has been argued that MVPA is less predictable on a day-to-day basis and requires longer monitoring periods to determine reproducible habitual behavior. 3, 4 In line with our results, a study that examined the reproducibility in accelerometer-assessed SB and PA reported the highest ICC values for SB. 17 It should be noted that ICC coefficients are restricted by the sample in which it was collected, because the magnitudes of intra-and inter-individual variability in SB and PA depends on the characteristics of the study sample. 30 Although the results reported in this study indicate that a 7-day accelerometry monitoring seems to be a reproducible measure of SB and PA, Bland Altman plots showed that there is a high intraindividual variability in SB and PA data. Therefore, the findings should be interpreted with caution and future studies are required to verify the findings of the present study using a larger sample of adults.
Our findings on accelerometer wear time highlight the importance of this factor. The value for the ICC coefficient of accelerometer wear time was the lowest of all outcomes. In terms of AMR, the systematic changes in time of wearing the accelerometer differed in the magnitude between the repeated measurements. In this regard, providing clear instructions to constantly wear the device to provide valid data at each measurement time point seems to be of great importance for the compliance of participants over time. 31 Accelerometer wear time was the only relevant predictor in all SB and PA regression models, whereas AMR operationalized by a reactivity indicator could not be identified as a relevant confounder for the reproducibility of PA and SB data. In line with other studies, this indicates that accelerometer wear time should be considered as a crucial confounder in data analysis of accelerometer data. 30, 32 To reduce AMR and, on the other hand, increase the precision of the measurement, a longer measurement period may be reasonable. Although a longer measurement period might improve reproducibility, the burden for study participants and study feasibility should be considered because it influences the response rate and compliance. 30 Some limitations have to be discussed. First, generalizability of our results may be compromised due to selection bias. The proportion of individuals who declined to participate was 44%. Non-participation could reduce study sample representativeness, 33 in the way that individuals who are more interested in their health or motivated to change their behavior are also more likely to participate. 34 In line with this finding, our sample seems to be compliant with an average accelerometer wear time of ≥ 14 h/day. As reactivity may be most pronounced in people with a high motivation to change their behavior, AMR may have been overestimated in our study. Second, we used hip-worn accelerometers that cannot differentiate between sitting and standing still because movement is determined by acceleration rather than body posture. 35 Thus, our findings regarding SB and LPA can give a distorted picture on AMR. Third, the inclusion of the intervention and assessment-only group in the analysis might have caused additional variation to the data, as the intervention group may (differentially) change their habitual SB and PA level over time. Unfortunately, our analyses of AMR separated by assessmentonly group and intervention group revealed no representative results due to their small sample sizes. Therefore, future studies are required to examine how intervention and control groups differ with regard to AMR using a larger sample. Finally, using the slope factor as a reactivity indicator to operationalize AMR is just one of several other ways to account for AMR for estimating the reproducibility of SB and PA data.
Conclusions
In conclusion, the results of the present study show that AMR differentially influences SB and PA in two measurement periods. Although a 7-day accelerometry monitoring seems to be a reproducible measure of SB and PA, our findings highlight the importance of accelerometer wear time as a crucial confounder when using accelerometer in monitoring SB and PA, planning interventions, and analyzing SB and PA data.
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